VSee Engages Philippine Health Leaders and Former VP Robredo in Southeast Asia expansion effort

Rhea-AI Summary

VSee Health (NASDAQ:VSEE) met with Philippine Tuberculosis Society and former vice president Leni Robredo (mayor of Naga City) on November 6, 2025 to explore digital health collaborations in Naga City focused on maternal health, primary care and TB testing.

Discussion highlighted Naga City gaps such as a 44% prenatal check-up rate versus the Department of Health target of 99%, use of mobile healthcare caravans, and PhilHealth's YAKAP subsidy of ₱1,700 (USD 29) per qualified patient for full primary care delivery. The release cites Southeast Asia digital health market size estimates of USD 17B (2024) growing to USD 38.8B by 2033, and the Philippines reaching USD 1B by 2027.

VSee noted ongoing Philippines projects (Project MAMA maternal health, TB screenings with Remedi and iOne Resource) as context for potential expansion and partnership-building in the region.

Positive

• SE Asia market size USD 17B in 2024
• Projected SE Asia market USD 38.8B by 2033
• Philippines market expected >USD 1B by 2027
• PhilHealth YAKAP provides ₱1,700 (USD 29) per qualified patient
• Existing partnerships: Project MAMA maternal health and TB screening collaborations

Negative

• Naga City prenatal check-up rate 44% vs DOH target 99%
• No binding commercial terms or revenue metrics disclosed for expansion

Insights

Global Health Partnerships Analyst

Engagement with Philippine leaders and NGOs signals a credible, scalable pilot in maternal and primary care delivery.

VSee's discussions with the Philippine Tuberculosis Society and Mayor Leni Robredo focus on deploying telehealth to raise low prenatal check-up rates (44% vs target 99%) and support primary care delivery tied to PhilHealth's YAKAP subsidy (₱1,700 / USD 29 per qualified patient). The business mechanism is straightforward: provide a secure, AI-enabled telehealth stack to extend clinical reach into mobile units and local clinics, enabling remote prenatal, TB screening, and data management workflows.

Key dependencies and risks include municipal buy-in, operational integration with PhilHealth's payment model, and measurable improvements in utilization and outcomes; none of these are guaranteed by a discussion alone. Watch for concrete agreements on funding, pilot scope, and data-sharing timelines within the next 6–12 months (6–12 months), since these will determine whether the engagement converts from conversation into a revenue-generating program.

Digital Health Market Strategist

This outreach supports regional expansion and positions VSee to tap Southeast Asia's growing digital health market.

The announcement frames VSee as leveraging prior Philippines projects (Project MAMA, TB screenings) to enter municipal-level pilots; the pathway to scale is to integrate with local NGOs, medtech partners, and satellite connectivity providers already named. The firm benefits if pilots prove interoperable with local workflows and if PhilHealth reimbursements materially flow to participating units.

Primary metrics to track are signed pilot contracts, patient volume under YAKAP, and any formal public-sector procurement milestones; monitor these over the coming 6–12 months for signs of tangible commercial progress. This is development-stage partnership news with positive strategic implications but uncertain near-term financial impact.

VSee explores collaboration with Philippine Tuberculosis Society and former VP Leni Robredo to expand digital health innovation for Naga City starting with maternal health and primary care

SAN JOSE, CALIFORNIA / ACCESS Newswire / November 6, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leading provider of secure, AI-powered telehealth technology, joined the Philippine Tuberculosis Society and former Philippine Vice President Leni Robredo (currently mayor of Naga City) to discuss opportunities to enhance healthcare delivery in Naga City through digital health innovation.

This initial discussion highlighted key healthcare challenges in Naga City, such as prenatal check-up rates-only 44% compared to the Department of Health's 99% target-and the city's efforts to expand access through healthcare caravans (mobile units) and health insurer PhilHealth's YAKAP project, which provides ₱1,700 (USD 29) per qualified patient to local government units delivering full primary care. Other areas of interest mentioned include TB testing and health data management.

This meeting underscores VSee Health's continued expansion and relationship-building in Southeast Asia-an emerging digital health market which reached USD 17 billion in 2024 and is projected to reach USD 38.8 billion by 2033 (iMarc, 2024). The Philippines, a key growth market in the region, is expected to surpass USD 1 billion by 2027 (Statista, 2024) as local and national governments accelerate digital transformation in healthcare.

VSee's AI-driven telehealth platform already supports projects such as Project MAMA, a maternal health initiative in partnership with Ateneo of Zambaneo University to decrease maternal and fetal deaths in remote rural Philippines, as well as ongoing collaborations with academic, NGO, innovative medtech, and government stakeholders. Most recently this includes TB screenings conducted in collaboration with MIT-founded medtech company Remedi, Inc., maker of ultra portable AI-enhanced X-ray devices and iOne Resource, satellite internet provider. These initiatives showcase the adaptability of VSee's technology to meet both primary care and specialty teleconsultation needs, helping providers extend care to hard-to-reach areas.

"With VSee's background of conducting telehealth initiatives for underserved regions of the Philippines over the past few years, this meeting marks an encouraging next step toward deepening partnerships that combine technology, clinical expertise, and public sector leadership to improve population health," said Milton Chen, PhD, Co-CEO of VSee Health. "We value the opportunity to explore how VSee's secure, scalable telehealth solutions can help expand access and strengthen local healthcare systems in the Philippines and throughout Southeast Asia."

About VSee Health

VSee Health (NASDAQ: VSEE) is an AI-powered telehealth technology and services company delivering digital health solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and enterprise partners globally. VSee holds a FedRAMP High Authority to Operate (ATO) from the U.S. Department of Health and Human Services and serves clients including NASA, HHS ASPR, McKesson, DaVita, and the country of Qatar. Visit vseehealth.com

Forward-Looking Statements

This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Certain of these forward-looking statements can be identified by the use of words such as "believes," "expects," "plans," "may," "should," "will," "seeks," or other similar expressions. Such statements may include, but are not limited to, statements regarding the Company's ability to regain compliance with Nasdaq's listing rules within the required timeframe. These statements are based on current expectations on the date of this press release and involve a number of risks and uncertainties that may cause actual results to differ significantly, including those risks set forth in the Company's most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-K and other SEC-filed documents. Such filing copies are available on the SEC's website www.sec.gov. The Company does not assume any obligation to update or revise any such forward-looking statements, whether as the result of new developments or otherwise. Readers are cautioned not to rely on forward-looking statements.

Media Contact:
Anne Chang
VSee Health
media@vsee.com

Investor Contact:
Milton Chen
VSee Health
investor@vsee.com

SOURCE: VSee Health

View the original press release on ACCESS Newswire

FAQ

What did VSee announce about expanding healthcare in Naga City (VSEE) on November 6, 2025?

VSee said it met Philippine Tuberculosis Society and former VP Leni Robredo to explore digital health collaborations in Naga City focused on maternal health, primary care and TB testing.

How does PhilHealth's YAKAP program affect potential VSEE projects in the Philippines (VSEE)?

PhilHealth's YAKAP provides ₱1,700 (USD 29) per qualified patient for full primary care, which could support local delivery models mentioned as part of VSee discussions.

What are the prenatal care challenges VSee highlighted for Naga City (VSEE)?

The release notes a 44% prenatal check-up rate in Naga City versus the Department of Health target of 99%, indicating room for outreach and telehealth support.

What market size projections did VSee cite for Southeast Asia digital health (VSEE)?

The company referenced estimates of USD 17B in 2024 growing to USD 38.8B by 2033, and the Philippines surpassing USD 1B by 2027.

Which existing VSee initiatives in the Philippines were mentioned (VSEE)?

VSee cited Project MAMA (maternal health), TB screenings with Remedi, and collaborations with academic, NGO and government stakeholders in the Philippines.